Article Text
Abstract
Background: Golabi, Ito, and Hall reported a family with X linked mental retardation (XLMR), microcephaly, postnatal growth deficiency, and other anomalies, including atrial septal defect, in 1984.
Methods: This family was restudied as part of our ongoing study of XLMR, but significant linkage to X chromosome markers could not be found. Extreme short stature and microcephaly as well as other new clinical findings were observed. Mutations in the polyglutamine tract binding protein 1 gene (PQBP1) have recently been reported in four XLMR disorders (Renpenning, Hamel cerebro-palato-cardiac, Sutherland-Haan, and Porteous syndromes) as well as in several other families. The clinical similarity of our family to these patients with mutations in PQBP1, particularly the presence of microcephaly, short stature, and atrial septal defect, prompted examination of this gene.
Results: A missense mutation in PQBP1 was identified which changed the conserved tyrosine residue in the WW domain at position 65 to a cysteine (p.Y65C).
Conclusions: This is the first missense mutation identified in PQBP1 and the first mutation in the WW domain of the gene. The WW domain has been shown to play an important role in the regulation of transcription by interacting with the PPxY motif found in transcription factors. The p.Y65C mutation may affect the proper functioning of the PQBP1 protein as a transcriptional co-activator.
- DHPLC, denaturing high performance liquid chromatography
- IPS, incorporation PCR SSCP
- MRX, non-syndromic XLMR
- PQBP1, polyglutamine tract binding protein 1 gene
- XLMR, X linked mental retardation
- Golabi-Ito-Hall syndrome
- microcephaly
- PQBP1
- Renpenning syndrome
- X linked mental retardation
Statistics from Altmetric.com
Footnotes
-
Grant support was provided by NICHD (HD 26202)
-
Competing interests: none declared
-
Patient details are published with consent